HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-MAY-16 5K00 TITLE MELK IN COMPLEX WITH NVS-MELK5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HMELK,PROTEIN KINASE EG3,PEG3 KINASE,PROTEIN KINASE PK38, COMPND 5 HPK38,TYROSINE-PROTEIN KINASE MELK; COMPND 6 EC: 2.7.11.1,2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MELK, KIAA0175; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) KEYWDS KINASE UBA TYPEII INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.R.SPRAGUE REVDAT 5 06-MAR-24 5K00 1 REMARK REVDAT 4 22-MAR-17 5K00 1 JRNL REVDAT 3 15-MAR-17 5K00 1 JRNL REVDAT 2 08-MAR-17 5K00 1 JRNL REVDAT 1 01-MAR-17 5K00 0 JRNL AUTH X.CHEN,J.GIRALDES,E.R.SPRAGUE,S.SHAKYA,Z.CHEN,Y.WANG,C.JOUD, JRNL AUTH 2 S.MATHIEU,C.H.CHEN,C.STRAUB,J.DUCA,K.HUROV,Y.YUAN,W.SHAO, JRNL AUTH 3 B.B.TOURE JRNL TITL "ADDITION" AND "SUBTRACTION": SELECTIVITY DESIGN FOR TYPE II JRNL TITL 2 MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE INHIBITORS. JRNL REF J. MED. CHEM. V. 60 2155 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28186750 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00033 REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 40242 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.196 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 2015 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2913 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2108 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2752 REMARK 3 BIN R VALUE (WORKING SET) : 0.2086 REMARK 3 BIN FREE R VALUE : 0.2499 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.53 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 161 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2537 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 235 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.36 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.35510 REMARK 3 B22 (A**2) : 7.54480 REMARK 3 B33 (A**2) : 2.81030 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.214 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.101 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.094 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.096 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.092 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2672 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3619 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 946 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 64 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 377 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2672 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 332 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3296 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.16 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.50 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -3.3551 -3.1028 10.6063 REMARK 3 T TENSOR REMARK 3 T11: -0.0402 T22: -0.1133 REMARK 3 T33: -0.0810 T12: -0.0164 REMARK 3 T13: 0.0075 T23: -0.0034 REMARK 3 L TENSOR REMARK 3 L11: 0.9474 L22: 0.9336 REMARK 3 L33: 1.4369 L12: -0.1699 REMARK 3 L13: 0.4580 L23: -0.3361 REMARK 3 S TENSOR REMARK 3 S11: -0.0125 S12: 0.0369 S13: 0.0238 REMARK 3 S21: -0.0257 S22: -0.0108 S23: 0.0416 REMARK 3 S31: -0.0337 S32: -0.0363 S33: 0.0232 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5K00 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-16. REMARK 100 THE DEPOSITION ID IS D_1000221521. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.20 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40469 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.768 REMARK 200 RESOLUTION RANGE LOW (A) : 67.403 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04200 REMARK 200 FOR THE DATA SET : 20.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.50400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM HEPES PH 7.6, 0.2M NACL, 13.3% REMARK 280 PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.73550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.31250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.70150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.31250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.73550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.70150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 21 REMARK 465 PHE A 22 REMARK 465 LYS A 158 REMARK 465 GLY A 159 REMARK 465 ASN A 160 REMARK 465 LYS A 161 REMARK 465 ASP A 162 REMARK 465 TYR A 163 REMARK 465 HIS A 164 REMARK 465 LEU A 165 REMARK 465 GLN A 166 REMARK 465 THR A 167 REMARK 465 CYS A 168 REMARK 465 CYS A 169 REMARK 465 GLY A 170 REMARK 465 LYS A 328 REMARK 465 PRO A 329 REMARK 465 VAL A 330 REMARK 465 HIS A 331 REMARK 465 HIS A 332 REMARK 465 HIS A 333 REMARK 465 HIS A 334 REMARK 465 HIS A 335 REMARK 465 HIS A 336 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 14 -159.51 -112.53 REMARK 500 ASP A 102 -59.53 76.67 REMARK 500 ARG A 131 -2.16 74.31 REMARK 500 TRP A 308 57.49 39.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6PV A 401 DBREF 5K00 A 3 330 UNP Q14680 MELK_HUMAN 3 330 SEQADV 5K00 MET A 2 UNP Q14680 INITIATING METHIONINE SEQADV 5K00 HIS A 331 UNP Q14680 EXPRESSION TAG SEQADV 5K00 HIS A 332 UNP Q14680 EXPRESSION TAG SEQADV 5K00 HIS A 333 UNP Q14680 EXPRESSION TAG SEQADV 5K00 HIS A 334 UNP Q14680 EXPRESSION TAG SEQADV 5K00 HIS A 335 UNP Q14680 EXPRESSION TAG SEQADV 5K00 HIS A 336 UNP Q14680 EXPRESSION TAG SEQRES 1 A 335 MET ASP TYR ASP GLU LEU LEU LYS TYR TYR GLU LEU HIS SEQRES 2 A 335 GLU THR ILE GLY THR GLY GLY PHE ALA LYS VAL LYS LEU SEQRES 3 A 335 ALA CYS HIS ILE LEU THR GLY GLU MET VAL ALA ILE LYS SEQRES 4 A 335 ILE MET ASP LYS ASN THR LEU GLY SER ASP LEU PRO ARG SEQRES 5 A 335 ILE LYS THR GLU ILE GLU ALA LEU LYS ASN LEU ARG HIS SEQRES 6 A 335 GLN HIS ILE CYS GLN LEU TYR HIS VAL LEU GLU THR ALA SEQRES 7 A 335 ASN LYS ILE PHE MET VAL LEU GLU TYR CYS PRO GLY GLY SEQRES 8 A 335 GLU LEU PHE ASP TYR ILE ILE SER GLN ASP ARG LEU SER SEQRES 9 A 335 GLU GLU GLU THR ARG VAL VAL PHE ARG GLN ILE VAL SER SEQRES 10 A 335 ALA VAL ALA TYR VAL HIS SER GLN GLY TYR ALA HIS ARG SEQRES 11 A 335 ASP LEU LYS PRO GLU ASN LEU LEU PHE ASP GLU TYR HIS SEQRES 12 A 335 LYS LEU LYS LEU ILE ASP PHE GLY LEU CYS ALA LYS PRO SEQRES 13 A 335 LYS GLY ASN LYS ASP TYR HIS LEU GLN THR CYS CYS GLY SEQRES 14 A 335 SER LEU ALA TYR ALA ALA PRO GLU LEU ILE GLN GLY LYS SEQRES 15 A 335 SER TYR LEU GLY SER GLU ALA ASP VAL TRP SER MET GLY SEQRES 16 A 335 ILE LEU LEU TYR VAL LEU MET CYS GLY PHE LEU PRO PHE SEQRES 17 A 335 ASP ASP ASP ASN VAL MET ALA LEU TYR LYS LYS ILE MET SEQRES 18 A 335 ARG GLY LYS TYR ASP VAL PRO LYS TRP LEU SER PRO SER SEQRES 19 A 335 SER ILE LEU LEU LEU GLN GLN MET LEU GLN VAL ASP PRO SEQRES 20 A 335 LYS LYS ARG ILE SER MET LYS ASN LEU LEU ASN HIS PRO SEQRES 21 A 335 TRP ILE MET GLN ASP TYR ASN TYR PRO VAL GLU TRP GLN SEQRES 22 A 335 SER LYS ASN PRO PHE ILE HIS LEU ASP ASP ASP CYS VAL SEQRES 23 A 335 THR GLU LEU SER VAL HIS HIS ARG ASN ASN ARG GLN THR SEQRES 24 A 335 MET GLU ASP LEU ILE SER LEU TRP GLN TYR ASP HIS LEU SEQRES 25 A 335 THR ALA THR TYR LEU LEU LEU LEU ALA LYS LYS ALA ARG SEQRES 26 A 335 GLY LYS PRO VAL HIS HIS HIS HIS HIS HIS HET 6PV A 401 42 HETNAM 6PV 4-{2-[(3-METHOXYPHENYL)AMINO]-4-[(PIPERIDIN-4-YL) HETNAM 2 6PV METHOXY]PYRIMIDIN-5-YL}-N-[2-OXO-2-(PHENYLAMINO) HETNAM 3 6PV ETHYL]BENZAMIDE FORMUL 2 6PV C32 H34 N6 O4 FORMUL 3 HOH *235(H2 O) HELIX 1 AA1 GLU A 6 LYS A 9 5 4 HELIX 2 AA2 LYS A 44 GLY A 48 1 5 HELIX 3 AA3 ASP A 50 ASN A 63 1 14 HELIX 4 AA4 LEU A 94 ASP A 102 1 9 HELIX 5 AA5 SER A 105 GLN A 126 1 22 HELIX 6 AA6 LYS A 134 GLU A 136 5 3 HELIX 7 AA7 SER A 171 ALA A 175 5 5 HELIX 8 AA8 ALA A 176 GLY A 182 1 7 HELIX 9 AA9 LEU A 186 GLY A 205 1 20 HELIX 10 AB1 ASN A 213 GLY A 224 1 12 HELIX 11 AB2 SER A 233 LEU A 244 1 12 HELIX 12 AB3 ASP A 247 ARG A 251 5 5 HELIX 13 AB4 SER A 253 ASN A 259 1 7 HELIX 14 AB5 HIS A 260 GLN A 265 1 6 HELIX 15 AB6 ASP A 283 VAL A 292 1 10 HELIX 16 AB7 ASN A 297 LEU A 307 1 11 HELIX 17 AB8 ASP A 311 GLY A 327 1 17 SHEET 1 AA1 5 TYR A 11 GLY A 18 0 SHEET 2 AA1 5 LYS A 24 HIS A 30 -1 O VAL A 25 N ILE A 17 SHEET 3 AA1 5 MET A 36 ASP A 43 -1 O ILE A 41 N LYS A 24 SHEET 4 AA1 5 LYS A 81 GLU A 87 -1 O LEU A 86 N ALA A 38 SHEET 5 AA1 5 LEU A 72 GLU A 77 -1 N TYR A 73 O VAL A 85 SHEET 1 AA2 3 GLY A 92 GLU A 93 0 SHEET 2 AA2 3 LEU A 138 PHE A 140 -1 O PHE A 140 N GLY A 92 SHEET 3 AA2 3 LEU A 146 LEU A 148 -1 O LYS A 147 N LEU A 139 SITE 1 AC1 21 ALA A 38 LYS A 40 LEU A 61 LEU A 64 SITE 2 AC1 21 CYS A 70 ASN A 80 LEU A 86 GLU A 87 SITE 3 AC1 21 TYR A 88 CYS A 89 PRO A 90 GLY A 92 SITE 4 AC1 21 GLU A 93 GLU A 136 LEU A 139 ILE A 149 SITE 5 AC1 21 ASP A 150 PHE A 151 ALA A 155 HOH A 502 SITE 6 AC1 21 HOH A 574 CRYST1 57.471 67.403 104.625 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017400 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014836 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009558 0.00000